quizartinib

FMS-like tyrosine kinase 3 ; Mus musculus







18 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33831397 Homoharringtonine synergizes with quizartinib in FLT3-ITD acute myeloid leukemia by targeting FLT3-AKT-c-Myc pathway. 2021 Jun 1
2 34288692 3H-Pyrazolo[4,3-f]quinoline-Based Kinase Inhibitors Inhibit the Proliferation of Acute Myeloid Leukemia Cells In Vivo. 2021 Aug 12 2
3 34362479 [Effect of FLT3-ITD Length on 32D Cell Proliferation, Apoptosis and Sensitivity to FLT3 Inhibitor]. 2021 Aug 2
4 32215183 Quizartinib, a selective FLT3 inhibitor, maintains antileukemic activity in preclinical models of RAS-mediated midostaurin-resistant acute myeloid leukemia cells. 2020 Mar 17 1
5 32629802 CXCR4 Inhibition Enhances Efficacy of FLT3 Inhibitors in FLT3-Mutated AML Augmented by Suppressed TGF-b Signaling. 2020 Jun 30 1
6 32999332 High-fat diet intensifies MLL-AF9-induced acute myeloid leukemia through activation of the FLT3 signaling in mouse primitive hematopoietic cells. 2020 Sep 30 1
7 30553002 P-glycoprotein (MDR1/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2) limit brain accumulation of the FLT3 inhibitor quizartinib in mice. 2019 Feb 10 2
8 30590794 Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activation. 2019 Nov 1 3
9 30770553 8-chloro-adenosine activity in FLT3-ITD acute myeloid leukemia. 2019 Feb 15 1
10 30923103 Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5-and hypoxia-dependent upregulation of AXL. 2019 Oct 3
11 29074603 Concurrent Inhibition of Pim and FLT3 Kinases Enhances Apoptosis of FLT3-ITD Acute Myeloid Leukemia Cells through Increased Mcl-1 Proteasomal Degradation. 2018 Jan 1 1
12 29187377 A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations. 2018 Jan 25 1
13 29854425 Flt3 Regulation in the Mononuclear Phagocyte System Promotes Ocular Neovascularization. 2018 1
14 28794285 Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib. 2017 Aug 9 2
15 29209657 Hitting the snooze button: Inducing quiescence with the FLT3 inhibitor quizartinib protects hematopoietic progenitors from chemotherapy. 2017 3
16 29212189 Quizartinib (AC220) reverses ABCG2-mediated multidrug resistance: In vitro and in vivo studies. 2017 Nov 7 5
17 27387666 Internal Tandem Duplication in FLT3 Attenuates Proliferation and Regulates Resistance to the FLT3 Inhibitor AC220 by Modulating p21Cdkn1a and Pbx1 in Hematopoietic Cells. 2016 5
18 22990016 Flt3 inhibitor AC220 is a potent therapy in a mouse model of myeloproliferative disease driven by enhanced wild-type Flt3 signaling. 2012 Nov 8 2